Trials / Conditions / MET Exon 14 Skipping Mutation
MET Exon 14 Skipping Mutation
3 registered clinical trials studyying MET Exon 14 Skipping Mutation — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Enrolling By Invitation | Integrated Genomics in Oncogene-driven NSCLC With Acquired Resistance NCT07122882 | Chang Gung Memorial Hospital | — |
| Recruiting | Neoadjuvant Immunotherapy in Rare Mutations Localized NSCLC NCT05800340 | Guangdong Provincial People's Hospital | Phase 2 |
| Unknown | Tepotinib in Solid Tumors Harboring MET Alterations NCT04647838 | Chungbuk National University Hospital | Phase 2 |